Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
BJOG. 2024 Jan;131(1):99-108. doi: 10.1111/1471-0528.17591. Epub 2023 Jul 2.
To study the impact of premenopausal risk-reducing salpingo-oophorectomy (RRSO), compared with postmenopausal RRSO, on urinary incontinence (UI) ≥10 years later.
Cross-sectional study, nested in a nationwide cohort.
Multicentre in the Netherlands.
750 women (68% BRCA1/2 pathogenic variant carriers) who underwent either premenopausal RRSO (≤45 years, n = 496) or postmenopausal RRSO (≥54 years, n = 254). All participants were ≥55 years at the time of the study.
Urinary incontinence was assessed by the urinary distress inventory-6 (UDI-6); a score ≥33.3 indicated symptomatic UI. The incontinence impact questionnaire short form (IIQ-SF) was used to assess the impact on women's health-related quality of life (HR-QoL). Differences between groups were analysed using regression analyses adjusting for current age and other confounders.
Differences in UDI-6 scores and IIQ-SF scores between women with a premenopausal and a postmenopausal RRSO.
Women in the premenopausal RRSO group had slightly higher UDI-6 scores compared with women in the postmenopausal RRSO group (P = 0.053), and their risk of symptomatic UI was non-significantly increased (odds ratio [OR] 2.1, 95% confidence interval [95% CI] 0.93-4.78). A premenopausal RRSO was associated with a higher risk of stress UI (OR 3.5, 95% CI 1.2-10.0) but not with urge UI. The proportions of women with a significant impact of UI on HR-QoL were similar in the premenopausal and postmenopausal RRSO groups (10.4% and 13.0%, respectively; P = 0.46).
More than 15 years after premenopausal RRSO, there were no significant differences in overall symptomatic UI between women with a premenopausal and those with a postmenopausal RRSO.
研究绝经前预防性输卵管卵巢切除术(RRSO)与绝经后 RRSO 相比,对 10 年后发生的尿失禁(UI)的影响。
全国性队列的嵌套横断面研究。
荷兰多中心。
750 名女性(68%为 BRCA1/2 致病性变异携带者),其中 496 名接受了绝经前 RRSO(≤45 岁),254 名接受了绝经后 RRSO(≥54 岁)。所有参与者在研究时均≥55 岁。
通过尿失禁困扰量表-6(UDI-6)评估尿失禁;评分≥33.3 表示有症状性 UI。使用尿失禁影响问卷短表(IIQ-SF)评估对女性健康相关生活质量(HR-QoL)的影响。使用回归分析调整当前年龄和其他混杂因素后,分析组间差异。
绝经前 RRSO 组与绝经后 RRSO 组之间 UDI-6 评分和 IIQ-SF 评分的差异。
与绝经后 RRSO 组相比,绝经前 RRSO 组的 UDI-6 评分略高(P=0.053),且发生症状性 UI 的风险无显著增加(比值比[OR]2.1,95%置信区间[95%CI]0.93-4.78)。绝经前 RRSO 与压力性 UI 的风险增加相关(OR 3.5,95%CI 1.2-10.0),但与急迫性 UI 无关。绝经前 RRSO 和绝经后 RRSO 组中 UI 对 HR-QoL 有显著影响的女性比例相似(分别为 10.4%和 13.0%;P=0.46)。
绝经前 RRSO 后 15 年以上,绝经前 RRSO 与绝经后 RRSO 相比,女性整体症状性 UI 无显著差异。